Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05966454Phase 4Terminated
Phase 4, randomised trial in appendicitis (2 arms), sponsored by University of California, San Francisco. Primary endpoints: Number of Participants With Infectious/Antibiotic Complication at 30 days and Number of Participant Deaths at 30 days. Started Jun 2023; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05966454.